Vanderbilt University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).

430 total trials 15 currently recruiting 343 completed early-phase tilt top decile by trial count

Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.

Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.

Top-decile sponsor footprint

Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

430 total, page 8 of 9

COMPLETED Phase 3

Nutrition and Resistance Training in Head and Neck Cancer

NCT00696553

COMPLETED Phase 1

Hydroxychloroquine in Cystic Fibrosis

NCT00311883

COMPLETED Phase 3

Adipose Secretory Function in Patients Before & After Laparoscopic Surgery

NCT00495599

COMPLETED NA

Improving Care for Patients With Diabetes and Poor Numeracy Skills

NCT00311922

COMPLETED NA

Effects of Grapefruit or Grapefruit Juice on Anthropometry, Dietary Intakes, Appetite, and Metabolic Profile in Overweight and Obese Young and Middle-Aged Adults

NCT00581074

COMPLETED NA

Autonomic Function in Obstructive Sleep Apnea

NCT00681161

COMPLETED

CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS

NCT00583167

TERMINATED NA

Selenium Supplementation of Patients With Cirrhosis

NCT00212212

TERMINATED

Effects of PA-1 Transcriptional Regulation on Monocyte Function

NCT00512369

COMPLETED NA

Safe Critical Care: Testing Improvement Strategies

NCT00975923

COMPLETED NA

Neurobiology and Treatment of Reading Disability in NF-1

NCT00624234

TERMINATED NA

Selenium Supplementation of Patients With Cirrhosis

NCT00271245

TERMINATED Phase 1

Botox vs. Baclofen for Upper Limb Spasticity

NCT00280280

COMPLETED

Optical Stimulation in Peripheral Nerves for Select Rhizotomy Procedures

NCT00575536

COMPLETED NA

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

NCT00288340

COMPLETED

Wound Repair and Body Contouring Surgery After Gastric Bypass

NCT00609037

COMPLETED Phase 1

Omentectomy for the Treatment of Diabetes Mellitus Type 2

NCT00270439

COMPLETED

Features to Predict Success With Nonoperative Treatment of Patients With Rotator Cuff Tears

NCT00762580

COMPLETED Phase 2

A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.

NCT00156689

TERMINATED

Growth Hormone's Effect on the Cardiovascular System

NCT00397319

COMPLETED Phase 2

Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

NCT00178841

COMPLETED NA

Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2

NCT00592332

TERMINATED Phase 2

Complementary Intradialytic Nutritional Supplementation in Dialysis Patients

NCT00179205

COMPLETED Phase 2

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

NCT00179218

COMPLETED Phase 2

Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

NCT00141778

COMPLETED Phase 2

The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis

NCT00179179

COMPLETED Phase 1

Aspirin Resistance in Systemic Lupus Erythematosus (SLE)

NCT00731302

COMPLETED NA

Using Baby Books to Promote Maternal and Child Health

NCT02203617

COMPLETED NA

Hypoglycemia Associated Autonomic Failure in Type 1 DM

NCT00592670

COMPLETED Phase 2

Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee

NCT00179153

COMPLETED

Ghrelin Changes After Roux-en-Y Gastric Bypass

NCT00765596

COMPLETED Phase 2

Effects of Brassica or Indole-3-carbinol on Prostatectomy Patients With PSA Recurrence

NCT00579332

COMPLETED Phase 2

The MIND Study: Modifying the INcidence of Delirium

NCT00096863

TERMINATED NA

Dopamine in Orthostatic Tolerance

NCT00748228

COMPLETED NA

The Clinical Informationist: Does the Model Work

NCT00226291

COMPLETED Phase 2

MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status

NCT00095251

COMPLETED Phase 3

Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression

NCT00179244

TERMINATED Phase 4

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

NCT00748371

TERMINATED Phase 2

Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure

NCT00179166

COMPLETED NA

Effects of Routine Feedback to Clinicians on Youth Mental Health Outcomes: A Randomized Cluster Design

NCT01308879

COMPLETED Phase 4

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

NCT00305396

COMPLETED

Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients

NCT00179101

COMPLETED Phase 1

Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain

NCT00178945

COMPLETED NA

Cognitive Behavioral vs. Interpersonal Therapy (IPT) Prevention of Depression in Adolescents

NCT00374439

TERMINATED Phase 2

Treatment of Orthostatic Hypotension

NCT00581477

COMPLETED Phase 1

Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery

NCT00201214

TERMINATED Phase 1

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

NCT00868855

COMPLETED NA

Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot

NCT00338208

COMPLETED

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

NCT00482586

COMPLETED Phase 2

Timing of Target Enteral Feeding in the Mechanically Ventilated Patient

NCT00252616

← Previous Page 8 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 42
Phase 3 10
Phase 4 32

What is open in the Vanderbilt University pipeline

15 recruiting of 430 indexed (3% open); 343 completed (80%).

Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).

Top condition: Obesity (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University: open-pipeline peers nationwide

Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%10%20%30% Total trials Recruiting share Vanderbilt UniversityUniversity of Illinois at ChicagoChildren's Hospital of PhiladelphiaNovo Nordisk A/SDartmouth-Hitchcock Medical CenterUSDA Grand Forks Human Nutrition Research CenterMedtronic MiniMedSandozSonova
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 430 trials (± recruiting share)

Sponsors near 3% open enrollment (± trial volume)

What to do with this Vanderbilt University page

430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.

  • 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.